Previous research has indicated a negative correlation between TIM‐4 and progression‐free survival in renal clear cell carcinoma patients,26 while high TIM‐4 expression is negatively correlated with overall survival in diffuse large B‐cell lymphoma, colorectal cancer, and lung cancer.27, 28, 29. This evidence concerns the gene TIMD4 and diffuse large B-cell lymphoma.